VXRT - Vaxart: A Speculative Buy For Its Oral COVID-19 Vaccine
Introduction
Vaxart (VXRT) is a small cap, clinical-stage biotech company based in South San Francisco, California that develops oral tablet vaccines to protect against infectious diseases caused by coronavirus, norovirus, seasonal influenza, respiratory syntactical virus (RSV), and for human papillomavirus (HPV).
its oral COVID-19 vaccine has been selected to participate in a non-human primate (NHP) challenge study, organized and funded by Operation Warp Speed, a new national program aiming to provide substantial quantities of safe, effective vaccine for Americans by January 2021".
Prior to the pandemic, the stock